October 24, 2024 argenx to Report Third Quarter 2024 Financial Results and Business Update on October 31, 2024
October 15, 2024 argenx Highlights Data Showing Patient Impact Across Multiple Immunology Programs at 2024 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting and Myasthenia Gravis Foundation of America Scientific Sessions
September 19, 2024 argenx Announces Publication in The Lancet Neurology of Pivotal ADHERE Study Data in Chronic Inflammatory Demyelinating Polyneuropathy
Follow us
Get the latest news and info via our social media channels.